Hoppscotch vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Open-source browser-based API testing platform with 500K+ developers; $3M seed from OSS Capital competing with Postman as a lightweight, self-hostable alternative for REST and GraphQL testing.
About
Hoppscotch is an open-source API development and testing platform — providing a web-based, lightweight alternative to Postman and Insomnia for building, testing, and documenting REST, GraphQL, WebSocket, and gRPC APIs. Founded in 2019 by Liyas Thomas and Andrew Bastin in Kochi, India, Hoppscotch has grown to 500,000+ developers globally using the platform, raised $3 million in seed funding led by OSS Capital with participation from Automattic (WordPress.com parent), and offers a free open-source version alongside Hoppscotch Pro cloud with team collaboration and private workspaces.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.